Page last updated: 2024-11-02

pioglitazone and Ataxia

pioglitazone has been researched along with Ataxia in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morgenweck, J1
Griggs, RB1
Donahue, RR1
Zadina, JE1
Taylor, BK1

Other Studies

1 other study available for pioglitazone and Ataxia

ArticleYear
PPARĪ³ activation blocks development and reduces established neuropathic pain in rats.
    Neuropharmacology, 2013, Volume: 70

    Topics: Anilides; Animals; Ataxia; CD11b Antigen; Dose-Response Relationship, Drug; Drug Administration Sche

2013